Literature DB >> 12014430

What is a pathogen?

Arturo Casadevall, Liise-anne Pirofski.   

Abstract

The question 'what is a pathogen?' derives from pathogen-centered views of microbial pathogenesis that invoke microbial characteristics to explain virulence. However, virulence cannot be an independent microbial variable since it is only expressed in a susceptible host. Hence, the question 'what is a pathogen?' cannot be separated from the question 'what is a host?' Given that virulence is an outcome of the host-microbe interaction that is not invariant from host to host, neither the pathogen or the host can be defined independently. To sidestep this paradox, one can focus on the outcome of the interaction using host damage as the common denominator to define and explain the various outcomes that can result from the host-microbe interaction. Using this concept a pathogen is defined as a microbe capable of causing host damage.

Entities:  

Mesh:

Year:  2002        PMID: 12014430     DOI: 10.1080/078538902317338580

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  14 in total

Review 1.  The Lung Microbiome and Its Role in Pneumonia.

Authors:  Benjamin G Wu; Leopoldo N Segal
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

Review 2.  Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens.

Authors:  L Jeannine Brady
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

3.  Host as the variable: model hosts approach the immunological asymptote.

Authors:  Arturo Casadevall
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

Review 4.  What is a host? Incorporating the microbiota into the damage-response framework.

Authors:  Arturo Casadevall; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2014-11-10       Impact factor: 3.441

5.  Examination of the pathogenic potential of Candida albicans filamentous cells in an animal model of haematogenously disseminated candidiasis.

Authors:  Ian A Cleary; Sara M Reinhard; Anna L Lazzell; Carlos Monteagudo; Derek P Thomas; Jose L Lopez-Ribot; Stephen P Saville
Journal:  FEMS Yeast Res       Date:  2016-02-05       Impact factor: 2.796

6.  Investigating the function of Ddr48p in Candida albicans.

Authors:  I A Cleary; N B MacGregor; S P Saville; D P Thomas
Journal:  Eukaryot Cell       Date:  2012-04-20

7.  Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient mice.

Authors:  Stephen P Saville; Anna L Lazzell; Ashok K Chaturvedi; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

Review 8.  The damage-response framework of microbial pathogenesis and infectious diseases.

Authors:  Liise-anne Pirofski; Arturo Casadevall
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 9.  Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs.

Authors:  Christopher G Pierce; Jose L Lopez-Ribot
Journal:  Expert Opin Drug Discov       Date:  2013-06-06       Impact factor: 6.098

10.  Validation of the tetracycline regulatable gene expression system for the study of the pathogenesis of infectious disease.

Authors:  Ashok K Chaturvedi; Anna L Lazzell; Stephen P Saville; Floyd L Wormley; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.